Open letter: Requesting clarification from J&J on the recent deal for generic bedaquiline supply

Treatment Action Group, Partners in Health and Medécins Sans Frontières wrote an open letter to Johnson & Johnson seeking clarification on its deal with Global Drug Facility to supply generic versions of TB drug bedaquiline and also reiterated its demand for a public announcement of non-enforcement of secondary patents on bedaquiline in all low-, lower-middle, upper-middle, and high-TB- or MDR-TB-burden countries.